Sign inJoin waitlistJoin the waitlist

AP

Angelo Pirozzi

Credentials:

History

Residency
2026–2029
Medical School
2022–2026

Research

Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
Hepatology · 2025 · 66 citations
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
JHEP Reports · 2025 · 17 citations
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
Journal of Hepatocellular Carcinoma · 2025 · 6 citations

Tanios Bekaii-Saab
9 papers
Celine Hoyek
8 papers · 8 as a resident
Mitesh Borad
6 papers
Mohamad Sonbol
6 papers
OA
Oluseyi Abidoye
6 papers · 6 as a fellow
Christina Wu
4 papers
Amit Singal
3 papers
AS
Anwaar Saeed
3 papers
Celina Ang
3 papers
Cody Eslinger
3 papers · 3 as a fellow
Daniel Ahn
3 papers
Brooke Wietharn
2 papers · 2 as a resident